A total of 11% of RSV patients experienced a cardiac event, abnormal heart rhythm, heart failure, or ischemic heart disease.
The loss of activity is equivalent to 15% of the US population becoming completely immobile for 1 day.
Adult COVID-19 patients also infected with the flu are 4 times more likely to need mechanical ventilation and 2.4 times more likely to die.
The roadmap offers a powerful opportunity to leverage advances in vaccine science to better protect against influenza, including pandemic flu.
The Influenza Vaccines Roadmaps Initiative newsletter highlights recent news, research, and events pertaining to influenza vaccine R&D.
A database of novel vaccine candidates that are designed to provide broader and more durable protection against influenza viruses.
Help support our work on influenza. Advance the work of CIDRAP in public health preparedness and emerging infectious disease response.
Receive the latest infectious disease information.
The COVID-19 pandemic dramatically worsened disparities in all-cause death rates for American Indian and Alaska Native (AIAN), Native Hawaiian, other Pacific Islander (NHOPI), and Black Americans and eroded mortality advantages for Asian and Hispanic groups, finds a study published yesterday in PNAS.
Boston public schools (BPS) yesterday announced the first monkeypox case in an "adult member of the BPS community," according to a letter sent to parents. The school district said the person was isolating at home, and the district was working to identify exposed individuals.
Researchers in Taiwan have discovered a new mutation in the SARS-CoV-2 Omicron BA.2.3.7 subvariant that they suggest may be responsible for severe neurologic complications observed in young children on the island. Their study was published yesterday in the International Journal of Infectious Diseases.
The Centers for Disease Control and Prevention (CDC) yesterday urged health providers to ask patients with suspected flu infections outside of the regular flu season to ask about any recent exposure to pigs.
A study published yesterday in JAMA Pediatrics suggests that long COVID is uncommon in children and teens and that risk factors include severe SARS-CoV-2 infection, younger age, and complex underlying chronic diseases.
The US Centers for Disease Control and Prevention defines long COVID as continuous, relapsing, or new symptoms or conditions persisting at least 1 month after the initial infection.
Following the Food and Drug Administration (FDA) emergency use authorization (EUA) of the Novavax COVID-19 vaccine last month for the primary vaccine series, the company announced today that it has applied for an EUA for the vaccine to also be used as a booster in adults ages 18 and older.
Maine, which has confirmed only four monkeypox cases, today reported a case of the virus in a resident under the age of 18. No further details were released by the Maine Centers for Disease Control. Maine now joins California and Florida as states with pediatric cases.
Also, researchers in Spain detail a possible human-to-dog case.
One day after the United States said it would allow intradermal, fractional dosing of Bavarian Nordic's monkeypox vaccine, Jynneos, the World Health Organization (WHO) called for more trials on the practice.
A systematic review and meta-analysis published yesterday in BMJ estimates that 5.6% of COVID-19 survivors may face long-lasting changes to their sense of smell or taste, adding to concerns about the overall burden of long COVID.
High estimated blood viscosity (eBV) is significantly associated with greater risk of death from complications among hospitalized COVID-19 patients, suggests a retrospective study published yesterday in the Journal of the American College of Cardiology.
